Herikîn

Personalised medicine promises to revolutionise healthcare; indeed, the generation of bespoke mRNA treatments has already shown great success in clinical trials for both congenital diseases and cancer. However, because these therapies are "n=1," the impending challenge of manufacturing thousands of unique therapeutics is significant and will drive the majority of the cost.

The Herikîn desktop—a simple, fully automated, and replicable process—is the ideal solution for a decentralised yet consistently supervised production system that solves this Scale-Out problem.

RNA-based Agri-product and biopesticides are paving way for "third revolution" in Agriculture. Targeted RNAi use that protect crops without leaving toxic residues that can sieve through the soil and water system, or carry over to our food chain. However, while farmers are eager to adopt these climate-friendly alternatives, high production costs remain the final barrier to adoption.

In collaboration with industry and government partners, Herikîn is bridging this gap. Our unique, fully automated hardware enables seamless scale-up and extremely low-cost RNA production.

mRNA is a versatile cornerstone of modern R&D, powering breakthroughs in vaccines, gene editing, and synthetic biology. mRNA is now the preferred tool for disease modeling and translation in primary cell lines, stem cells or in vivo. However, the cycle of iteration, like all biological production remains long. This slows science.

The Herikîn Lab is dismantling this barrier by enabling one-click, full-length mRNA synthesis in under 24 hours, accelerating the pace of discovery from weeks to hours.